Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20015505HPVENSG00000105388.17protein_codingCEACAM5NoNo1048A0A024R0K5
P06731
TVIS20015576HPVENSG00000105388.17protein_codingCEACAM5NoNo1048A0A024R0K5
P06731
TVIS20015527HPVENSG00000105388.17protein_codingCEACAM5NoNo1048A0A024R0K5
P06731
TVIS20070131HPVENSG00000105388.17protein_codingCEACAM5NoNo1048A0A024R0K5
P06731
TVIS20015526HPVENSG00000105388.17protein_codingCEACAM5NoNo1048A0A024R0K5
P06731
TVIS20027181HPVENSG00000105388.17protein_codingCEACAM5NoNo1048A0A024R0K5
P06731
TVIS20027180HPVENSG00000105388.17protein_codingCEACAM5NoNo1048A0A024R0K5
P06731
TCGA Plot Options
Drug Information
GeneCEACAM5
DrugBank IDDB05097
Drug NameLabetuzumab
Target IDBE0004224
UniProt IDP06731
Regulation Typeinhibitor
PubMed IDs19789330
CitationsGovindan SV, Cardillo TM, Moon SJ, Hansen HJ, Goldenberg DM: CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates. Clin Cancer Res. 2009 Oct 1;15(19):6052-61. doi: 10.1158/1078-0432.CCR-09-0586. Epub 2009 Sep 29.
GroupsInvestigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL